Recent news on

Lethal injection creator: Maybe it's time to change formula  -  Apr 30, 2007
CNN International..."Now there are other agents that work much faster and much easier," Chapman said, specifically pointing out an anesthetic called Diprivan.

Pierson’s journey  -  Feb 6, 2007
Tuscaloosa News (subscription),The medical name is Diprivan, but anesthesiologists have nicknamed it “magic milk." The medicine didn’t take long to take effect.

United States: Court Narrows Literal Construction, But Catches ...  -  Dec 1, 2006
Mondaq News Alerts (subcription),Abraxis filed suit following Mayne's Abbreviated New Drug Application (ANDA) submission for a generic version of DIPRIVAN including a structural derivative

Cottageville Mayor Toxicology Report  -  Dec 6, 2006
WCBD-TV,Diprivan is a prescription drug which often is used as a sedative and as anesthesia because it reportedly reduces anxiety and promotes sleep.

RFID EXOTICA: RFID is no longer a high-tech bean counter  -  Dec 6, 2006
Enterprise Networks & ServersThe biggest RFID application in Healthcare is the 40 million tags delivered for error prevention on AstraZeneca anaesthetic Diprivan used in operating

CONSCIOUS SEDATION  -  Dec 1, 2006
EndoNurse,The problem with propofol (brand name Diprivan) is that it is considered by the FDA to be an anesthetic agent, and should be administered by persons trained

Anesthetics may Increase Risk of Alzheimer's Disease  Oct 26, 2006
...bind. Use of isoflurane is also on the decline. However, the intravenous propofol, also called Diprivan, is commonly used today. In ... -Ivanhoe, Radio Shipment-Tracking: A Revolution Delayed  Oct 8, 2006
Eight years ago, AstraZeneca (AZN) began tagging syringes for delivery to Europe and Japan of an anaesthesia called Diprivan, which is used during surgery. ... -BusinessWeek Opportunities in pharmaceutical RFID and smart packaging  Sep 5, 2006
...in using an electronic handshake based on an innovative form of "chipless" RFID for error prevention and recording procedures with Diprivan anaesthetic, over ... -MTBeurope

Cottageville Mayor Toxicology Report  -  Dec 6, 2006
WCBD-TV,Diprivan is a prescription drug which often is used as a sedative and as anesthesia because it reportedly reduces anxiety and promotes sleep.

United States: Court Narrows Literal Construction, But Catches ...  -  Dec 1, 2006
Mondaq News Alerts (subcription),Abraxis filed suit following Mayne's Abbreviated New Drug Application (ANDA) submission for a generic version of DIPRIVAN including a structural derivative

Mayne Loses Appeal Over Generic Propofol  -  Nov 17, 2006
WTOP,AstraZeneca has sold the patents and registration of Diprivan to Abraxis BioScience Inc. "Mayne Pharma is therefore prohibited from marketing its Propofol

US court rules against Mayne on propofol  -  Nov 16, 2006
The Age,AstraZeneca has sold the patents and registration of Diprivan to Abraxis BioScience. At the release of its annual results in September, Mayne estimated that

Australia's Mayne Pharma injectable anaesthesia drug blocked by US ...  -  Nov 16, 2006
Forbes,AstraZeneca sold the patents and registration of Diprivan to Abraxis BioScience. As a result of the court's ruling Mayne Pharma is prohibited from marketing

Mayne Pharma loses propofol court battle  -  Nov 16, 2006
Courier Mail,AstraZeneca has sold the patents and registration of Diprivan to Abraxis BioScience. Mayne shares were one cent lower at $4.22 at 1115 AEDT today.

Australia's Mayne Pharma injectable anaesthesia drug blocked by US ...  -  Nov 16, 2006
Euro2day,AstraZeneca sold the patents and registration of Diprivan to Abraxis BioScience. As a result of the court''s ruling Mayne Pharma is prohibited from

Mayne Loses Appeal Over Generic Propofol  -  Nov 17, 2006
Washington Post,Circuit over a court decision last year that its formulation infringed patents held by AstraZeneca PLC, the innovator of Propofol, branded as Diprivan.

Mayne Pharma loses propofol court battle  -  Nov 16, 2006
The Australian,District of New York that Mayne's propofol formulation infringed patents held by AstraZeneca, the innovator of Propofol which is branded as Diprivan.

Mayne loses appeal over generic Propofol  -  Nov 17, 2006
Meadow Free Press,AstraZeneca has sold the patents and registration of Diprivan to Abraxis BioScience Inc. Last month Hospira Inc., the largest US maker of generic injectable

VITAL SIGNS - The pharmaceuticals and biotechnology synopsis  -  Nov 17, 2006
egoli.com.au,AstraZeneca has sold the patents and registration of Diprivan to Abraxis BioScience. Singapore-based diagnostics company, Rockeby biomed Limited (RBY),

RFID EXOTICA: RFID is no longer a high-tech bean counter  -  Dec 6, 2006
Enterprise Networks & ServersThe biggest RFID application in Healthcare is the 40 million tags delivered for error prevention on AstraZeneca anaesthetic Diprivan used in operating

CONSCIOUS SEDATION  -  Dec 1, 2006
EndoNurse,The problem with propofol (brand name Diprivan) is that it is considered by the FDA to be an anesthetic agent, and should be administered by persons trained

Opportunities in Pharmaceutical RFID and Smart Packaging - By Dr ...  Aug 3, 2006
...in using an electronic handshake based on an innovative form of "chipless" RFID for error prevention and recording procedures with Diprivan anaesthetic, over ... -Packaging & Converting Essentials

Abraxis Completes AstraZeneca Products Buy  Jun 29, 2006
Products in this acquisition encompass over 100 dosage forms and include the leading branded anesthetic agent, Diprivan, and Naropin, as well as a ... -International News Service

Abraxis BioScience Completes Acquisition of the AstraZeneca US ...  Jun 29, 2006
Products in this acquisition encompass over 100 dosage forms and include the leading branded anesthetic agent, Diprivan(R) (propofol), and Naropin(R ... -dBusinessNews Los Angeles

Abraxis BioScience Completes Acquisition Of US Branded Anesthetic ...  Jun 28, 2006
...under the US branded anesthetic and analgesic product portfolios include Xylocaine, Polocaine, Nesacaine, Astramorph, Sensorcaine, Diprivan, Naropin, and EMLA ... -Trading Markets



AstraZeneca and Abraxis exchange drug programs  Apr 28, 2006
The anesthetic and analgesic products acquired by Abraxis encompass over 100 dosage forms and include the leading branded anesthetic agent, Diprivan, and a ... - Pharmaceutical Business Review

Abraxis BioScience Announces Co-Promotion Agreement with ...  Apr 26, 2006
These products encompass over 100 dosage forms and includethe leading branded anesthetic agent, Diprivan(R) (propofol), and aproprietary Naropin(R) (ropivacaine ... - Finanzen.net

Guest Column: RFID's Increasingly Rapid Adoption in Healthcare  May 5, 2006
Indeed, the largest use of RFID in healthcare so far by numbers of tags is the 40 million used for error prevention on AstraZeneca Diprivan syringes. ... - Supply & Demand Chain Executive

Abraxis BioScience Announces Co-Promotion Agreement with ...  Apr 27, 2006
These products encompass over 100 dosage forms and include the leading branded anesthetic agent, Diprivan(R) (propofol), and a proprietary Naropin(R ... - PharmaLive.com

AstraZeneca makes $200M deal with Abraxis  Apr 27, 2006
US branded anesthetics and analgesic products including Xylocaine, Polocaine, Naropin, Nesacaine, Sensorcaine, Astramorph, Emla Cream, and Diprivan. ... - BusinessWeek

Astrazeneca and Abraxis Bioscience to Co-promote Cancer Therapy ...  Apr 27, 2006
The products covered by the agreement (Xylocaine, Polocaine, Naropin, Nesacaine, Sensorcaine, Astramorph, Emla Cream, and Diprivan) had US sales of ... - PharmaLive.com





Rewarding Patient Investors?  Apr 5, 2006
...to launch nine or more new drug compounds this year, two of which — Propofol, a generic form of a sedative that AstraZeneca sells as Diprivan, and Ondansetron ... - Smartmoney.com

Routine Inhaled Induction in Adults: A Safe Practice?  Jan 29, 2006
...surgery. Acta Anaesthesiol Scand 1998;42:658-63.[ISI][Medline]. Diprivan 1% (propofol). Patient information leaflet. AstraZeneca ... - Anesthesia & Analgesia (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional